Jerome Durso

2020

In 2020, Jerome Durso earned a total compensation of $3.9M as Chief Operating Officer at Intercept Pharmaceuticals, a 9% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$231,737
Option Awards$998,776
Salary$599,524
Stock Awards$2,057,016
Other$21,910
Total$3,908,963

Durso received $2.1M in stock awards, accounting for 53% of the total pay in 2020.

Durso also received $231.7K in non-equity incentive plan, $998.8K in option awards, $599.5K in salary and $21.9K in other compensation.

Rankings

In 2020, Jerome Durso's compensation ranked 2,923rd out of 13,090 executives tracked by ExecPay. In other words, Durso earned more than 77.7% of executives.

ClassificationRankingPercentile
All
2,923
out of 13,090
78th
Division
Manufacturing
1,127
out of 5,618
80th
Major group
Chemicals And Allied Products
419
out of 2,251
81st
Industry group
Drugs
362
out of 1,951
81st
Industry
Pharmaceutical Preparations
266
out of 1,456
82nd

Pay ratio

Jerome Durso's Pay$3,908,963
Median Employee's Pay$267,493
Pay Ratio

15

to 1

In 2020, the annual total compensation of Jerome Durso was $3,908,963.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $267,493.

The ratio of Jerome Durso's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 27, 2021.

Durso's colleagues

We found six more compensation records of executives who worked with Jerome Durso at Intercept Pharmaceuticals in 2020.

2020

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2020

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

2020

Richard Kim

Intercept Pharmaceuticals

Former President, U.S. Commercial & Strategic Marketing

2020

Lisa Bright

Intercept Pharmaceuticals

Former President, International

2020

Ryan Sullivan

Intercept Pharmaceuticals

General Counsel

2020

Christian MAS

Intercept Pharmaceuticals

EVP, Research & Development

News

You may also like